Mitochondrial diseases are a large family of extremely heterogeneous disorders genetically determined by mutations in either the nuclear genome or the mitochondrial DNA. Most of the mitochondrial disease genes are expressed in all cell types. However, in many conditions, some cell types are more affected than others. However, the reasons for this tissue-specificity remain poorly understood. To investigate the functional basis of the striking tissue-specificity in mitochondrial diseases, we analyzed several bioenergetic parameters, including oxygen consumption rates, Q redox poise, and reactive oxygen species production in mouse brain and liver mitochondria fueled by different substrates. In addition, we determined how these functional parameters are affected by electron transport chain impairment in a tissue-specific manner using pathologically relevant mouse models lacking either Ndufs4 or Ttc19, leading to complex I or III defects, respectively. No cure is currently available for most of the mitochondrial diseases. We previously showed that the coordinated activation of autophagy, lysosomal biogenesis, and mitochondrial biogenesis by rapamycin, ameliorated the myopathic phenotype of a muscle-specific knockout mouse for Cox15 (Cox15sm), encoding an enzyme involved in heme A biosynthesis. However, the role of mitophagy has been poorly investigated. We found that urolithin A, a direct mitophagy inducer, improved motor performance and myopathy in the Cox15sm mice, without increasing the activity of the respiratory chain complexes in a 10 week-treatment. These results indicate that activation of mitophagy can be a suitable treatment to ameliorate mitochondrial myopathies.

Many animal species are remarkably resilient to the harmful conditions of hypoxia and reoxygenation, a phenomenon widely observed across many species and environmental settings. The ability to survive oxygen deprivation and reintroduction without significant cellular damage is partially attributed to the upregulation of antioxidants, a strategy termed "Preparation for Oxidative Stress" (POS). The concept of POS is that by producing more antioxidants under hypoxia animals would anticipate the eventual and potentially damaging reintroduction of oxygen. Historically, the specific mechanisms through which POS is activated remained elusive. Over the past decade, significant advancements have been made in understanding POS at a molecular level and in identifying its widespread in the animal kingdom. Notably, a detailed molecular mechanism for the activation of POS under conditions of low oxygen availability has been proposed, emphasizing the role of reactive oxygen species in modulating antioxidant response through redox-sensitive transcription factors. Furthermore, recent research has demonstrated the occurrence of POS in free-ranging animals under completely natural settings, confirming its ecological and physiological relevance. Despite recent advancements, some aspects of POS remain underexplored and should be prioritized in future research. These include the experimental validation of the mechanisms proposed to underlie POS and the assessment of the relevance of POS in multi-stressor scenarios, particularly to understand how organisms cope with combined stressors in fluctuating environments.

Regular physical exercise (PE) leads to a systemic adaptation to redox homeostasis perturbation, one of the hallmarks of exercise adaptation. Studies have shown that PE can alter the molecular composition of extracellular vesicles (EVs), impacting their ability to communicate with other cells and modulate physiological processes. EVs circulating in the body and secreted from various cell types, including skeletal muscle cells, contain various regulatory molecules and mediate intercellular communications and tissue cross-talk. Considering that the health-related benefits of a physically active lifestyle are partially driven by various bioactive molecules released into the circulation during exercise, collectively termed “exerkines”, there has been a rapidly growing interest in the role of EVs cargo as “carriers” in the multi-systemic, adaptive response to exercise. Indeed, a potential mechanism by which plasma EVs released during exercise impact ageing and diseases related to redox impairment is increased delivery of redox components, such as redox transcription factors and antioxidants. This presentation will offer a general overview of the biology of exercise-induced EVs and their putative role in health maintenance and disease prevention, with a focus on redox homeostasis control.  

Rett syndrome (RTT), a devastating neurodevelopmental disorder, is caused in 95% of the cases by mutations in the X-chromosome-localized MECP2 gene. RTT manifests as a range of multisystem disturbances including altered lipid profile, subclinical inflammation, and overall OxInflammatory status in which mitochondrial dysfunction acts as central player. To decipher the molecular mechanisms underlying the pathophysiological manifestations affecting patients, we investigated whether mitochondria may play a role in the aberrant immune and oxidative responses of RTT. Recent findings from our and other labs unraveled several abnormalities in RTT mitochondria including atypical mitochondrial structure, deregulated expression of genes encoding oxidative phosphorylation factors and mitochondrial organization factors, impaired mitochondrial quality control, depressed energetic profile, and augmented mt-ROS production. In other brain diseases, mitochondrial dysfunction is a vital event during the activation of NLPR3 inflammasome, a multi-protein complex involved in innate immune response, that represents a common denominator in the crosstalk between inflammation and oxidative stress. Interestingly, using primary fibroblasts and lympho-monocytes isolated from RTT patients, we found a constitutive hyperactivation of NLRP3:ASC inflammasome associated with increased levels of nuclear p65 and ASC proteins, and pro-IL-1β mRNA, without the ability to further respond to the LPS + ATP stimuli. Furthermore, increased circulating levels of ASC, interleukin (IL)-18, and 1β were found in RTT individuals, thus corroborating the aforementioned cellular findings. In order to evaluate NLRP3 involvement in the transition from pre-symptomatic to symptomatic phase of RTT, we detected higher serum levels of IL-1β and IL-18 in symptomatic Het mice compared to WT. Of note, increased gene expression of Il-1b, Nlrp3, and ASC was observed in Het brains at the pre-symptomatic stage, suggesting a likely role of NLRP3 impairment in the early stages of the disease. Preliminary data showed that treatment with resveratrol, known to improve mitochondrial function, ameliorated the RTT mouse phenotype by restoring levels of some NLRP3-related components. Furthermore, mitochondrial dysfunction can result in ferroptosis, a form of cell death characterized by iron-dependent lipid peroxidation and accumulation of reactive oxygen species.  After treatment with two ferroptosis inducers, erastin (GPX4 inhibitor) or RSL3 (inhibitor of the cystine/glutamate antiporter), we found changes in GPx and GR activity, alteration in GPX4 protein levels and increased formation of 4HNE protein adducts. Mitochondrial ROS production and lipid peroxidation levels were higher in RTT after ferroptosis induction, while co-treatment with ferrostatin-1, a well-known inhibitor of ferroptosis, significantly prevented these processes. Interestingly, co-treatment with mito-TEMPO, a mitochondria-targeted superoxide dismutase mimetic, mitigated mitochondrial oxidative burden and prevented ferroptosis cell death in RTT cells. Overall, our results demonstrate the decisive role of mitochondrial dysfunction in RTT OxInflammation. Thus, we can speculate that exposure of RTT cells to any condition affecting the already compromised mitochondrial function could not only hyperactivate the inflammatory status but also precipitate ferroptosis cell death. Targeting mitochondria in RTT could represent a strategic coadjuvant therapy to improve the quality of life of the affected patients.

Mitochondrial production of O₂^•– and H₂O₂ has been implicated in redox signaling and in the pathogenesis of numerous diseases including cancer, neurodegeneration, and cardiovascular diseases. To understand the exact role of those species, new chemical biology tools for selective and efficient induction of mitochondrial superoxide production are needed. Here, we report the development of a new viologen-based redox cycling agent, mito-diquat (Mito-DQ), capable of inducing targeted mitochondrial O₂^•– production at significantly higher rates as compared to previously reported mito-paraquat (Mito-PQ), a widely used chemical tool to study mitochondria-dependent redox signaling.

Our recent observations show that both resistant and stem-like cancer cells predominantly responsible for metastasis differ from chemotherapy-sensitive cells. We have shown bioinformatically and experimentally that mitochondria of such cells are much more prone to oxidative phosphorylation (OXPHOS) than radio- or chemotherapy-sensitive cancer cells from which they evolved during therapeutic interventions. Specifically, in triple-negative breast cancer models, we observed that such resistant cells exhibit higher mitochondrial membrane potential, higher OXPHOS and respiration, and increased resistance to oxidative stress, allowing them to survive chemo-radiotherapy.  These findings of increased expression of OXPHOS-associated genes and proteins in chemoresistant cells and biopsies of relapsed tumors suggest an alternative druggable target. Our in vitro and in vivo (nude mice and Artemia salina) data suggest that certain antibiotics, inducers of mitochondrial dysfunction, create additive oxidative stress and can reduce the growth rate of tumors developed from resistant or stem-like cancer cells. Such repurposed drugs, selected from a chemical library, are also able to resensitize resistant tumors, allowing reuse of chemotherapeutic agents. In addition, their modification with a specific moiety (TPP) allows for increased delivery to mitochondria to reduce cytotoxic pressure on normal cells. Thus, research from our laboratory offers an alternative strategy for anticancer therapy of resistant tumors.

Thyroid hormones play an important role in both testis development and spermatogenesis. While hypothyroidism has been known to generally induce metabolic suppression, lower respiration rate, and reduce free radical formation, recent studies reported an increased production of reactive oxygen species (ROS). First line of antioxidant defense in testes is comprised of two isoforms of superoxide dismutase (SOD), CuZnSOD and MnSOD differently localised in cell. This study aimed to investigate the effects of hypothyroidism on the expression, localisation, and activity of these two SOD isoforms during spermatogenesis. Hypothyroidism was induced in two-month-old male Wistar rats by 0.04% methimazole in drinking water for 7, 15, and 21 days, while euthyroid control group drank tap water. CuZnSOD protein expression was decreased after 15 and 21 days while its activity was decreased by 40% in all examined time points of methimazole treatment in comparison to euthyroid control. At the same time, neither MnSOD protein expression nor its activity was changed by treatment. However, cell and stage-specific CuZnSOD and MnSOD immunoexpression in the rat testes were changed in hypothyroidism and may contribute to the altered spermatic characteristics. Our results suggest that changes in CuZnSOD and MnSOD expression play role in redox disbalance leading to hypothyroidism-induced maturation arrest of spermatogenesis.

Small cell lung cancer (SCLC) is the leading cause of cancer-related deaths worldwide and is characterized by rapid growth, early metastasis, and high mortality rates. This study investigated the prognostic potential of leukocyte telomere length (LTL) and paraoxonase 1 (PON1) activity in 60 SCLC patients treated with a cisplatin/etoposide (PE) regimen. Patients were observed at baseline, after 2 cycles, and after 4 cycles of chemotherapy. The primary objective was to evaluate the prognostic potential of these biomarkers for patient survival. LTL was measured from isolated genomic DNA using real-time quantitative polymerase chain reaction (RTq-PCR), while PON1 activity was determined using a spectrophotometric method. A Kaplan-Meier survival analysis was performed with cut-off values below the 25^th percentile for LTL and PON1 activity to determine their prognostic power for overall survival. The analysis revealed that both LTL and PON1 are significant predictors of patient survival, suggesting that patients with levels below the 25^th percentile have a higher risk of death (Log Rank = 3.956, p = 0.047; Log Rank = 3.834, p = 0.050, respectively). Telomeres, the protective caps at the ends of chromosomes, shorten with each cell division and reflect cell aging and genomic stability. Shorter telomere lengths in leukocytes have been associated with a poorer prognosis and lower survival rates in SCLC patients. Similarly, reduced PON1 activity is associated with increased oxidative stress, which contributes to cancer progression and poorer clinical outcomes. Monitoring PON1 activity could help in assessing patient prognosis and adjusting treatment strategies. These findings suggest that LTL and PON1 activity have significant prognostic value in SCLC and serve as useful indicators for identifying high-risk patients and guiding treatment decisions to improve outcomes.

Variations in body size and shape might be linked to different biological processes that affect breast cancer risk. Еpidemiological studies have confirmed that obesity, which is characterized by increased overall adiposity and assessed using body mass index (BMI), has direct relationship with the risk of breast cancer among postmenopausal women, and opposite relationship with the risk among premenopausal women (“obesity paradox”). In addition to BMI, anthropometric descriptors of body shape, like waist and hip circumference and waist-to-hip ratio are directly associated with both pre- and postmenopausal breast cancer risk. Excess adipose tissue, adipose tissue dysfunction, and adipose tissue-to-breast cancer crosstalk have important role in the initiation and progression of breast cancer due to the altered production of proinflammatory and proangiogenic mediators, growth factors, adipokines, and sex hormones, dysregulated insulin signaling pathway, as well as mitochondrial dysfunction and oxidative stress. Fat distribution pattern exerts an effect beyond the effect of overall obesity in relation to breast cancer development because of more adverse systemic metabolic effects related to visceral adiposity. Body height and its components have direct association with postmenopausal breast cancer risk. Increased risk of breast cancer in taller persons is probably due to increased levels of insulin-like growth factor (IGF-1), which is one of the major determinants of height, plays an important role in regulating breast stem cell number, and can affect cancer growth. Adult-attained height also reflects different aspects of maturation, including genetic, nutritional, and environmental factors. Assessment of changes in body height, mass, and distribution of adipose tissue throughout life is another important aspect of understanding the complex processes of metabolic reprogramming of energy pathways in breast cancer pathophysiology. Use of anthropometric descriptors of body size and shape can provide insight into underlying biological mechanisms, which is essential for developing targeted prevention and treatment strategies.

This research was supported by the Science Fund of the Republic of Serbia, #7750238, Exploring new avenues in breast cancer research: Redox and metabolic reprogramming of cancer and associated adipose tissue - REFRAME.

One of the adaptive features that organisms developed throughout their long natural history is the ability to change the activity of cells, tissues, and organs on a daily, 24-hour, basis. These cyclical changes are synchronized to the external environment through a light-dark regime and internal circadian clock. Daily recurring environmental changes are followed by variations in animal behavior and physiology, which include oscillations in neuroendocrine, metabolic, cardiovascular, and immune functions. By transforming the circadian periodicity of day, artificial light from anthropogenic sources might interfere with organisms leading to a disturbance in hormone levels and physiological stress. In this study, we investigated daily natural variations in the antioxidant system and the effects of artificial light on the redox balance in larvae of tree frogs. We compared antioxidant parameters in tadpoles from the natural day/night cycle (control) with ones exposed to artificial light at night (treatment). The antioxidant response was measured at four time points during 24h (morning, day, evening, and night). Our results showed that only GR activity did not display day/night changes nor was affected by night illumination. For GSH-Px and GST we reported changes in activity at different times of day that were in the same manner for both treatment and control. The highest values were in the morning compared to the other time points. Variation during 24h was also observed for SOD, CAT and GSH. However, exposure to night light affected the pattern and intensity of these parameters compared to the control group. Overall our study suggests that daily differences in metabolic activity can result in variations in the antioxidant system and that the presence of artificial light affects these changes. The disrupted natural rhythm of the antioxidant response may further reflect on other physiological processes and lead to a state of oxidative stress.